Bariatric Surgery Outcomes in Patients with Severe Obesity Compared to Patients with Non-Severe Obesity at A New Institution in The United Arab Emirates.
Jamie P DeCiccoJuan S Barajas-GamboaJerry T DangGabriel Diaz Del GobboJaved RazaCarlos AbrilAlfredo D GuerronJuan Pablo PantojaSafa Botros HegazinRicard CorcellesJohn RodriguezMatthew KrohPublished in: Journal of clinical medicine (2024)
Background: Bariatric surgery is an effective treatment for weight loss, but a higher body mass index (BMI) may lead to higher postoperative complication rates. This study aims to compare perioperative and postoperative outcomes between UAE patients with severe obesity (SO) [BMI ≥ 50 kg/m 2 ] and non-severe obesity (NSO) [BMI < 50 kg/m 2 ] undergoing primary bariatric surgery. Methods : From September 2015 to July 2019, 542 patients, 94 SO (56.5 ± 6.2 kg/m 2 ) and 448 NSO (41.8 ± 4.1 kg/m 2 ), were retrospectively reviewed. Results : Patients with SO were younger (33.8 ± 13.4 vs. 37.0 ± 11.5 years, p = 0.02) but otherwise had similar demographic characteristics. Their rates of Roux-en-Y gastric bypass (39.4% SO vs. 44.4% NSO, p = 0.37) and sleeve gastrectomy (60.6% vs. 55.6%, p = 0.37) were similar. There were no differences between perioperative complications (6.4% SO vs. 5.8% NSO, p = 0.83), major postoperative complications (5.3% vs. 3.5%, p = 0.42), readmissions (5.3% vs. 3.3%, p = 0.36), or reoperations (3.2% vs. 2.7%, p = 0.78). There were no mortalities. Their total body weight loss was comparable at 12 months (28.1 ± 10.2% vs. 29.0 ± 7.7%, p = 0.58). Conclusions : Although a higher BMI may pose operative challenges, UAE patients with SO do not have worsened outcomes in bariatric surgery, demonstrating similarly low morbidity to patients with NSO, and similar rates of improvement in their BMI.
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- body mass index
- weight gain
- obese patients
- gastric bypass
- patients undergoing
- glycemic control
- early onset
- end stage renal disease
- ejection fraction
- type diabetes
- newly diagnosed
- cardiac surgery
- chronic kidney disease
- insulin resistance
- risk factors
- metabolic syndrome
- skeletal muscle
- drug induced
- replacement therapy
- combination therapy